Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Moderna CEO: COVID variant vaccine to be ready for shipping in August

Published 06/22/2022, 03:03 AM
Updated 06/22/2022, 03:06 AM
© Reuters. FILE PHOTO: The Moderna COVID-19 vaccine sits on the table at Trinity United Church of Christ in Chicago, Illinois, U.S., February 13, 2021.  REUTERS/Kamil Krzaczynski/File Photo

LONDON (Reuters) - Moderna (NASDAQ:MRNA)'s COVID-19 variant vaccine will be ready to ship in August as the company has been making shots ahead of approval, Chief Executive Stephane Bancel told Reuters on Wednesday, adding that the only bottleneck to supply was a regulatory one.

"Our goal is as early as August given we're going to file all the data in June, by the end of June... hopefully in the August timeframe, the vaccine is authorised," Bancel said in an interview.

"We can start shipping in the August timeframe. Some countries might be September, but that will really be a regulatory decision. Because what is (the) bottleneck now is regulatory. From a manufacturing standpoint, we are making the vaccine."

Latest comments

This vaccine is a hoax scheme to let people addicted with no real effect and many unknown side effects
more people have died without it then have died with it. so your common is mainly so you can try to tank it. and then buy even lower so you can make money.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.